Liraglutide No Match for Heart Failure in Early Round of FIGHTLiraglutide No Match for Heart Failure in Early Round of FIGHT

In the FIGHT trial of patients with advanced HF, the GLP-1 agonist liraglutide did not improve survival or rates of rehospitalization at 6 months. Heartwire from Medscape
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news